Allianz Asset Management GmbH Buys 81,293 Shares of Sabra Healthcare REIT, Inc. $SBRA

Allianz Asset Management GmbH lifted its stake in Sabra Healthcare REIT, Inc. (NASDAQ:SBRA) by 9.9% in the 3rd quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 902,998 shares of the real estate investment trust’s stock after acquiring an additional 81,293 shares during the period. Allianz Asset Management GmbH owned 0.38% of Sabra Healthcare REIT worth $16,832,000 at the end of the most recent quarter.

Other hedge funds have also recently made changes to their positions in the company. Focus Partners Wealth raised its stake in shares of Sabra Healthcare REIT by 11.4% during the 1st quarter. Focus Partners Wealth now owns 23,146 shares of the real estate investment trust’s stock worth $404,000 after acquiring an additional 2,375 shares in the last quarter. Ameritas Advisory Services LLC acquired a new position in shares of Sabra Healthcare REIT during the second quarter worth $84,000. KLP Kapitalforvaltning AS lifted its holdings in shares of Sabra Healthcare REIT by 7.4% during the 2nd quarter. KLP Kapitalforvaltning AS now owns 49,500 shares of the real estate investment trust’s stock valued at $913,000 after purchasing an additional 3,400 shares during the last quarter. Monument Capital Management acquired a new stake in shares of Sabra Healthcare REIT in the 2nd quarter worth $276,000. Finally, Aberdeen Group plc boosted its position in shares of Sabra Healthcare REIT by 0.7% in the 2nd quarter. Aberdeen Group plc now owns 911,331 shares of the real estate investment trust’s stock worth $16,805,000 after purchasing an additional 6,474 shares in the last quarter. 99.40% of the stock is currently owned by hedge funds and other institutional investors.

Sabra Healthcare REIT Stock Performance

Shares of SBRA stock opened at $19.03 on Friday. Sabra Healthcare REIT, Inc. has a 52-week low of $15.60 and a 52-week high of $19.97. The company has a quick ratio of 5.19, a current ratio of 5.19 and a debt-to-equity ratio of 0.92. The stock has a market cap of $4.75 billion, a PE ratio of 26.43, a price-to-earnings-growth ratio of 1.32 and a beta of 0.67. The business has a 50-day simple moving average of $19.00 and a 200-day simple moving average of $18.72.

Sabra Healthcare REIT (NASDAQ:SBRA) last released its quarterly earnings results on Wednesday, November 5th. The real estate investment trust reported $0.38 EPS for the quarter, beating the consensus estimate of $0.37 by $0.01. The company had revenue of $190.04 million for the quarter, compared to analyst estimates of $193.44 million. Sabra Healthcare REIT had a net margin of 23.50% and a return on equity of 6.38%. The firm’s revenue was up 6.7% on a year-over-year basis. During the same quarter last year, the business earned $0.37 earnings per share. On average, equities analysts expect that Sabra Healthcare REIT, Inc. will post 1.45 EPS for the current year.

Sabra Healthcare REIT Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Friday, February 27th. Shareholders of record on Friday, February 13th will be given a dividend of $0.30 per share. The ex-dividend date is Friday, February 13th. This represents a $1.20 dividend on an annualized basis and a yield of 6.3%. Sabra Healthcare REIT’s dividend payout ratio is currently 166.67%.

Analysts Set New Price Targets

SBRA has been the topic of several recent analyst reports. Wells Fargo & Company upped their price objective on shares of Sabra Healthcare REIT from $20.00 to $21.00 and gave the company an “overweight” rating in a report on Tuesday, November 25th. UBS Group initiated coverage on shares of Sabra Healthcare REIT in a research note on Tuesday, November 18th. They set a “neutral” rating and a $20.00 price target on the stock. National Bankshares set a $22.00 price target on shares of Sabra Healthcare REIT in a report on Friday, October 17th. Jefferies Financial Group reissued a “buy” rating and set a $22.00 price objective on shares of Sabra Healthcare REIT in a report on Monday, December 15th. Finally, Truist Financial raised their target price on Sabra Healthcare REIT from $20.00 to $21.00 and gave the stock a “hold” rating in a research note on Tuesday, January 20th. Four equities research analysts have rated the stock with a Buy rating and five have given a Hold rating to the company. According to MarketBeat.com, the stock currently has an average rating of “Hold” and an average target price of $21.11.

Sabra Healthcare REIT Profile

Sabra Healthcare REIT, Inc (NASDAQ: SBRA) is a real estate investment trust that acquires, owns and operates net‐lease healthcare properties. Its diversified portfolio spans senior housing communities, skilled nursing and rehabilitation centers, outpatient medical facilities, medical office buildings, hospitals and life science properties. Sabra structures long‐term, triple‐net lease agreements with healthcare operators, providing stable rental income streams while allowing tenants to focus on patient care and operational excellence.

Serving a broad spectrum of care segments, Sabra’s tenants include both regional and national providers of assisted living, independent living, memory care, post‐acute rehabilitation and research and development laboratories.